Showing results (1451-1460 of 2,063) with videos related to
Sort By:
Pageof 207
Brachytherapy|November 8, 2022
Prostate brachytherapy utilization in the COVID-19 era: A cross-sectional study of radiation oncologists in the United StatesRahul N Prasad, Yevgeniya Gokun, Alex R Ritter, et al.Brachytherapy|August 22, 2025
Evaluation of variability in applicator position and organs at risk dose in fractionated intracavitary brachytherapy for cervical cancerFrancis Kazoba, Elingarami Sauli, Elias Nyanza, et al.Brachytherapy|August 22, 2025
Intraoperative low-dose rate brachytherapy as an adjunct to surgery for marginally resectable rectal and recurrent anorectal carcinomasMustafa M Al Balushi, Teresia M Perkins, Kee-Young Shin, et al.Brachytherapy|December 11, 2025
A mediation analysis of laboratory indicators affecting seed migration after 125I brachytherapy in hepatic malignanciesJunfeng Lin, Ang Li, Jianqiang Ye, et al.Brachytherapy|December 14, 2025
Association between rectal spacer use and bowel, urinary, and sexual dysfunction following prostate cancer brachytherapy: U.S. claims data analysisMichael R Folkert, Emily S Weg, Ryoko Sato, et al.Brachytherapy|December 5, 2025
National patterns of brachytherapy boost use for intermediate- and high-risk prostate cancer: Bridging the gap between evidence and practiceAlicia C Smart, Yetkin Tuac, Zhiyu Qian, et al.Brachytherapy|January 25, 2026
Treatment and outcomes of primary urethral cancer treated with radiation therapyBenjamin D Hopkins, David C Qian, Tony Y Eng, et al.Brachytherapy|January 23, 2026
Improved outcomes in primary hepatocellular carcinoma adjacent to large vessels: A combined approach of MRI-guided radiofrequency ablation and 125I implantationXianhua Miao, Rui Guo, Qingfeng Lin, et al.Brachytherapy|January 7, 2026
Ultrasound and CT-guided 125I implantation combined with TACE therapy in the treatment of recurrent HCC after RFANingjie Li, Ping Yang, Jun Fang, et al.Brachytherapy|January 13, 2026
A review on the transition from PDR to HDR brachytherapy (interventional radiotherapy) for treatment of head and neck cancer: Clinical and practical aspectsRenske van Noortwijk, Petra Kroon, Maarten Kastelijns, et al.Pageof 207